Healthcare Regulatory & Qui Tam Defense Insurance in Delaware

Delaware at a glance

State false claims statute

Delaware False Claims and Reporting Act

Permits qui tam relator suits with Attorney General intervention discretion.

Fraud enforcement office

Delaware Department of Justice, Medicaid Fraud Control Unit

Tracks a comparatively small, concentrated set of major providers statewide.

Healthcare ecosystem

Wilmington-area health systems and regional clinical research

Sector concentration means one referral pattern can draw comparative review across affiliated systems.

Insurance regulator

Delaware Department of Insurance

Confirm current licensing and filing guidance directly with the department.

A concentrated provider base changes the enforcement dynamic

Delaware's healthcare sector is smaller and more concentrated than most of its neighbors, centered on Wilmington-area health systems and a modest but active regional clinical-research presence. Because the Medicaid Fraud Control Unit within the Department of Justice tracks a comparatively small set of major providers, a billing irregularity flagged at one system can prompt comparative review across others in the same referral network, even absent direct evidence tying them together.

The Delaware False Claims and Reporting Act's relator provisions

Delaware's False Claims and Reporting Act permits private relators to file qui tam actions in the Court of Chancery or Superior Court depending on the relief sought, and the Attorney General's Fraud and Consumer Protection Division decides whether to intervene. Because Delaware's corporate and business-court infrastructure is unusually well developed relative to its population, procedural motions in a Delaware qui tam matter can move through a more specialized judicial process than in many larger states, which affects timing expectations for defense counsel.

Coastal exposure informs but does not replace program-integrity controls

While Delaware's coastal geography drives many of its property-risk conversations, healthcare regulatory exposure here turns on billing audits, exclusion-list screening, and referral-arrangement review rather than weather. Providers should maintain documented overpayment-identification and self-disclosure processes consistent with both the state Medicaid program's protocol and, where applicable, the federal OIG process; fines, penalties, and knowing misstatements remain outside what insurance can address.

Confirm current relator-share rules and DOJ practice with counsel

Delaware's false claims relator-share percentages and Fraud and Consumer Protection Division intervention practices are subject to change; confirm current figures before relying on a past matter as precedent.

Who we write this for in Delaware

Healthcare regulatory defense FAQs for Delaware